535 related articles for article (PubMed ID: 19855238)
1. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Opelz G; Daniel V; Naujokat C; Döhler B
Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
[TBL] [Abstract][Full Text] [Related]
2. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
3. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
Saghafi H; Qorashi M; Heidari A
Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
[TBL] [Abstract][Full Text] [Related]
8. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation.
Li L; Chaudhuri A; Weintraub LA; Hsieh F; Shah S; Alexander S; Salvatierra O; Sarwal MM
Pediatr Transplant; 2007 Mar; 11(2):187-95. PubMed ID: 17300499
[TBL] [Abstract][Full Text] [Related]
9. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
Schaffer K; Hassan J; Staines A; Coughlan S; Holder P; Tuite G; McCormick AP; Traynor O; Hall WW; Connell J
Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
12. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.
Le Page AK; Mackie FE; McTaggart SJ; Kennedy SE
Nephrology (Carlton); 2013 Dec; 18(12):813-9. PubMed ID: 23927085
[TBL] [Abstract][Full Text] [Related]
14. [CMC and EBV infections in children].
Polz-Dacewicz M; Stec A; Koncewicz R
Przegl Epidemiol; 2002; 56(1):65-72. PubMed ID: 12150069
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
Shahinian VB; Muirhead N; Jevnikar AM; Leckie SH; Khakhar AK; Luke PP; Rizkalla KS; Hollomby DJ; House AA
Transplantation; 2003 Mar; 75(6):851-6. PubMed ID: 12660514
[TBL] [Abstract][Full Text] [Related]
16. Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients.
Barzon L; Murer L; Pacenti M; Biasolo MA; Vella MD; Ghirardo G; Gamba PG; De Arias AE; Zanon GF; Palù G
J Infect Dis; 2009 Nov; 200(9):1425-33. PubMed ID: 19803803
[TBL] [Abstract][Full Text] [Related]
17. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus in pediatric patients after renal transplantation.
Schwab M; Böswald M; Korn K; Ruder H
Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
[TBL] [Abstract][Full Text] [Related]
19. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]